Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178253-14-000020
Filing Date
2014-11-13
Accepted
2014-11-13 10:26:30
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q scyx-20140930x10q.htm 10-Q 1179302
2 EX-31.1 q32014exhibit311.htm EX-31.1 12075
3 EX-31.2 q32014exhibit312.htm EX-31.2 12240
4 EX-32.1 q32014exhibit321.htm EX-32.1 8679
  Complete submission text file 0001178253-14-000020.txt   7100782

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT scyx-20140930.xml EX-101.INS 992594
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT scyx-20140930.xsd EX-101.SCH 55846
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT scyx-20140930_cal.xml EX-101.CAL 67984
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT scyx-20140930_def.xml EX-101.DEF 231226
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT scyx-20140930_lab.xml EX-101.LAB 586429
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT scyx-20140930_pre.xml EX-101.PRE 365870
Mailing Address 3501-C TRICENTER BLVD DURHAM NC 27713
Business Address 3501-C TRICENTER BLVD DURHAM NC 27713 919-544-8600
SCYNEXIS INC (Filer) CIK: 0001178253 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36365 | Film No.: 141216700
SIC: 2834 Pharmaceutical Preparations